Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy

Respiratory syncytial virus (RSV) infection is the most frequent cause of hospitalization in infants and young children worldwide. Although mucosal RSV vaccines can reduce RSV disease burden, little is known about mucosal immune response capabilities in children. Neonatal or adult mice were infected...

Descripción completa

Detalles Bibliográficos
Autores principales: Hijano, Diego R., Siefker, David T., Shrestha, Bishwas, Jaligama, Sridhar, Vu, Luan D., Tillman, Heather, Finkelstein, David, Saravia, Jordy, You, Dahui, Cormier, Stephania A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056463/
https://www.ncbi.nlm.nih.gov/pubmed/30038294
http://dx.doi.org/10.1038/s41598-018-29456-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056463/
https://www.ncbi.nlm.nih.gov/pubmed/30038294
http://dx.doi.org/10.1038/s41598-018-29456-w

Ejemplares similares